Nanordica Medical has been selected as a finalist in the Deeptech of the Year category at the Estonian Startup Awards 2024. The awards recognize leading science-driven startups making a measurable impact in their fields.

Our nomination highlights the progress we have made in developing nanotechnology-based antibacterial wound dressings. In 2024, we launched one of the most ambitious clinical trials for diabetic foot ulcers, secured multiple distribution agreements, and accelerated regulatory approval in the EU.

Being shortlisted among Estonia’s top deeptech startups reflects the growing role of scientific innovation in healthcare. We are grateful for the recognition and excited about the next steps in bringing our solutions to patients.

Read more about the awards on Lift99.